DE1966821B2 - and its acid addition salts - Google Patents

and its acid addition salts

Info

Publication number
DE1966821B2
DE1966821B2 DE1966821A DE1966821A DE1966821B2 DE 1966821 B2 DE1966821 B2 DE 1966821B2 DE 1966821 A DE1966821 A DE 1966821A DE 1966821 A DE1966821 A DE 1966821A DE 1966821 B2 DE1966821 B2 DE 1966821B2
Authority
DE
Germany
Prior art keywords
acid addition
addition salts
hydrazide
compound
seryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE1966821A
Other languages
German (de)
Other versions
DE1966821A1 (en
DE1966821C3 (en
Inventor
Giuseppe Dr. Basel Bartholini
Balthasar Dr. Binningen Hegedues
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE1966821A1 publication Critical patent/DE1966821A1/en
Publication of DE1966821B2 publication Critical patent/DE1966821B2/en
Application granted granted Critical
Publication of DE1966821C3 publication Critical patent/DE1966821C3/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C243/34—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a carbon skeleton further substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

Die Erfindung betrifft ein neues,
abgeleitetes Hydrazid der Formel:The invention relates to a new,
derived hydrazide of the formula:

von L-Serinof L-serine

HO-< VcH = N-NH-CO-CH-CH,OH (1)HO- <VcH = N-NH-CO-CH-CH, OH (1)

HOHO

OHOH

NH,NH,

Erhöhung von CA in
arbiträren EinheitenIncrease of CA in
arbitrary units

sowie Säureadditionssalze !hiervon.as well as acid addition salts!

Die erfindungsgemäßen Verbindungen sind Zwischenverbindungen zur Herstellung von Ni-L-Seryl-N2-(2,3,4-trihydroxy-benzyl)-hydrazid sowie dessen Säureadditionssalzen. Die letztgenannte Verbindung -weist pharmakologische Wirkung auf, und zwar besitzt sie eine decarboxylasehemmende Wirkung, wobei von besonderem Interesse ist, daß sie in Kombination mit L-Dopa hervorragende Mittel zur Behandlung von Parkinsonismus darstellt und antidepressiv wirkt. Zum Nachweis der Überlegenheit wurden die von L-Dopa induzierten Erhöhungen von Catecholaminen (CA) im Gehirn durch Verwendung vonThe compounds according to the invention are intermediate compounds for the preparation of Ni-L-seryl-N2- (2,3,4-trihydroxy-benzyl) hydrazide as well as its acid addition salts. The latter connection has pharmacological effect, namely it has a decarboxylase-inhibiting effect, with of of particular interest is that they are combined with L-Dopa excellent means of treating Represents Parkinsonism and has an antidepressant effect. As evidence of its superiority, those of L-Dopa induced elevations of catecholamines (CA) in the brain through the use of

1. 12 mg/kg N,-D,L-Serin-N-(2,3,4-trihydroxybenzyi)-hydrazid-hydrochlorid. Produkt des Beispiels 3 der deutschen Patentschrift 11 65 607
(Verbindung E in der nachstehenden Tabelle),1. 12 mg / kg N, -D, L-serine-N- (2,3,4-trihydroxybenzyi) -hydrazide hydrochloride. Product of example 3 of German patent specification 11 65 607
(Compound E in the table below),

2. einer äquimolaren Menge von Ni-D.L-Alanin-N2-(2,3,4-trihydroxybenzyl)-hydrazid-hydrochlorid. Produkt des Beispiels 6 derselben
Patentschrift (Verbindung F), und2. an equimolar amount of Ni-DL-alanine-N 2 - (2,3,4-trihydroxybenzyl) hydrazide hydrochloride. Example 6 product of the same
Patent specification (compound F), and

100100

11,5 13611.5 136

Daraus ergibt sich, daß die Verbindung G eine größere decarboxylaseheminende Wirkung hat als die bekannten Verbindungen E und F.As a result, Compound G has a greater decarboxylase-inhibiting effect than that known compounds E and F.

Die erfindungsgemäße Verbindung der Formel I und deren Salze können nach an sich bekannten Methoden erhalten werden, beispielsweise durch Umsetzung eines Säureadditionssalzes von L-Scrinhydrazid mit 2,3,4-Trihydroxy-benzaldehyd. The compound of the formula I according to the invention and its salts can be prepared by methods known per se be obtained, for example by reacting an acid addition salt of L-scrinhydrazide with 2,3,4-trihydroxy-benzaldehyde.

Die erfindungsgemäße Verbindung der Formel I kann durch katalytische Hydrierung in das pharmakologisch aktive Ni-L-Seryl-N2-(2,3,4-trihydroxybenzyl)-hydra/.id übergeführt werden.The compound of the formula I according to the invention can be converted into the pharmacologically by catalytic hydrogenation active Ni-L-Seryl-N2- (2,3,4-trihydroxybenzyl) -hydra / .id can be converted.

Beispielexample

Herstellung von N|-L-Seryl-N2-(2,3,4-trihydroxybenzylider.)-hydrazid-hydrochlorid Production of N | -L-Seryl-N2- (2,3,4-trihydroxybenzylider.) - hydrazide hydrochloride

15,4 g 2,3,4-Trihydroxybenzaldehyd werden in 200 ml siedendem Wasser gelöst und auf einmal mit 15,2 g L-Serin-hydrazid-hydrochlorid versetzt. Man erhält eine klare Lösung. Diese wird unter vermindertem Druck eingeengt und durch portionenweise Zugabe von Äthanol wird das Wasser allmählich verdrängt. Hierbei entsteht ein Kristallbrei. Dieser wird genutscht und mit Äthanol und Äther gewaschen. Man erhält das N|-L-Seryl-N>-(2,3,4-trihydiOxy-benzyliden)-hydrazidhydrodilorid vom F. = 260-2650C [λ]»= +23" (c = 1: H2O).15.4 g of 2,3,4-trihydroxybenzaldehyde are dissolved in 200 ml of boiling water, and 15.2 g of L-serine hydrazide hydrochloride are added all at once. A clear solution is obtained. This is concentrated under reduced pressure and the water is gradually displaced by adding ethanol in portions. This creates a crystal pulp. This is sucked up and washed with ethanol and ether. The N | -L-Seryl-N> - (2,3,4-trihydiOxy-benzylidene) -hydrazidhydrodilorid of F. = 260-265 0 C [λ] >> = +23 "(c = 1: H 2 O).

Claims (3)

Patentanspruch:Claim: Ni-L-Seryl-N2-(2,3,4-trihydroxy-benzylidtn)-hydrazid und dessenSäureadditionssalze.Ni-L-Seryl-N2- (2,3,4-trihydroxy-benzylid-n) hydrazide and its acid addition salts. 3. einer äquimolaren MengedesNi-L-Serin-Ni-(2,3,4-trihydroxybenzyl)-hydrazid-hydrochlorids (Verbindung G)3. An equimolar amount of the Ni-L-serine-Ni (2,3,4-trihydroxybenzyl) hydrazide hydrochloride (Compound G) bei Ratten gemessen, wobei sich folgende Werte ergeben:measured in rats, resulting in the following values: Verbindunglink E F GE F G
DE1966821A 1968-08-16 1969-08-13 Ni.i ^ »> i-N2 - (23.4-trihydroxy-benzylidene) hydrazide and its acid addition salts Expired DE1966821C3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1240368A CH554844A (en) 1968-08-16 1968-08-16 METHOD OF MANUFACTURING A HYDRAZIDE.

Publications (3)

Publication Number Publication Date
DE1966821A1 DE1966821A1 (en) 1974-07-11
DE1966821B2 true DE1966821B2 (en) 1978-03-16
DE1966821C3 DE1966821C3 (en) 1978-11-23

Family

ID=4382677

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1966821A Expired DE1966821C3 (en) 1968-08-16 1969-08-13 Ni.i ^ »> i-N2 - (23.4-trihydroxy-benzylidene) hydrazide and its acid addition salts
DE1941284A Expired DE1941284C3 (en) 1968-08-16 1969-08-13 N to the power of 1-L-Seryl-N to the power of 2- (2,3,4trihydroxybenzyl) hydrazide, process for its preparation and its acid addition salts and pharmaceuticals containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1941284A Expired DE1941284C3 (en) 1968-08-16 1969-08-13 N to the power of 1-L-Seryl-N to the power of 2- (2,3,4trihydroxybenzyl) hydrazide, process for its preparation and its acid addition salts and pharmaceuticals containing them

Country Status (16)

Country Link
JP (1) JPS5114501B1 (en)
AT (2) AT299158B (en)
BE (1) BE737420A (en)
CA (1) CA958418A (en)
CH (1) CH554844A (en)
CS (1) CS162689B2 (en)
DE (2) DE1966821C3 (en)
DK (1) DK126776B (en)
ES (1) ES370500A1 (en)
FR (2) FR2015792B1 (en)
GB (1) GB1250279A (en)
IE (1) IE33519B1 (en)
IL (1) IL32767A (en)
MY (1) MY7300018A (en)
NL (1) NL6912320A (en)
SE (1) SE378242B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103951587A (en) * 2014-04-11 2014-07-30 浙江耐司康药业有限公司 Synthetic method for intermediate of benserazide hydrochloride
WO2015197909A1 (en) 2014-06-27 2015-12-30 Fermion Oy Process for the preparation of a crystalline polymorph of 2-amino-3-hydroxy-n'-(2,3,4-trihydroxybenzyl)propanehydrazide (benserazide) hydrochloride

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065265A (en) * 1957-07-04 1962-11-20 Hoffmann La Roche Amino acid hydrazides

Also Published As

Publication number Publication date
CH554844A (en) 1974-10-15
GB1250279A (en) 1971-10-20
IL32767A0 (en) 1969-11-12
IL32767A (en) 1973-01-30
AT299160B (en) 1972-06-12
DE1941284A1 (en) 1970-02-19
DE1941284B2 (en) 1974-05-30
FR2015792B1 (en) 1973-08-10
AT299158B (en) 1972-06-12
SE378242B (en) 1975-08-25
BE737420A (en) 1970-02-13
NL6912320A (en) 1970-02-18
DK126776B (en) 1973-08-20
JPS5114501B1 (en) 1976-05-10
DE1941284C3 (en) 1975-01-30
ES370500A1 (en) 1971-04-16
CS162689B2 (en) 1975-07-15
FR2104722A1 (en) 1972-04-21
IE33519L (en) 1970-02-16
DE1966821A1 (en) 1974-07-11
DE1966821C3 (en) 1978-11-23
MY7300018A (en) 1973-12-31
IE33519B1 (en) 1974-07-24
FR2015792A1 (en) 1970-04-30
FR2104722B1 (en) 1974-03-22
CA958418A (en) 1974-11-26

Similar Documents

Publication Publication Date Title
DE1802162A1 (en) New N-pyridylmethylidene homocysteine thiolactone compound and process for its preparation
DE1966821C3 (en) Ni.i ^ »&gt; i-N2 - (23.4-trihydroxy-benzylidene) hydrazide and its acid addition salts
DE1545772B1 (en) 7- (3&#39;-picolylamino-alkyl) -theophyllins and their nicotinic acid salts
DE2008332C3 (en) 2-methyl-S-methoxy-3-indolylacetohydroxamic acids, processes for their preparation and pharmaceuticals containing these compounds
DE1966804C3 (en) N1 -Glycine-N2 - (2,3,4-trihydroxy-benzylidene) -
DE69328357T2 (en) COMPLEX OF 2-AMINOETHANESULPHONIC ACID AND ZINC
DE844299C (en) Process for the preparation of a new condensation product of 2- (p-aminobenzenesulfonamido) pyrimidine
DE2132113C3 (en) Derivatives and analogs of naphthoxybutyramidine and their addition salts with acids, their preparation and pharmaceutical compositions containing them
AT157575B (en) Process for the production of undecomposed, sterilizable drug solutions from the double compound theophylline-piperazine.
DE1695832C3 (en) B1,3-biphenylpyrazoline derivatives and process for their preparation
AT137334B (en) Process for the preparation of N- [n-propyl] -5.5-phenylethylbarbitic acid.
DE115287C (en)
DE1122514B (en) Process for the preparation of hypertensive 2-AEthyl-3,3-diphenyl-propen- (2) -yl-amine
DE2427382A1 (en) 3-BENZYLPYRIDO SQUARE CLAMP ON 3.4 SQUARE CLAMP FOR -AS-TRIAZINE AND METHOD OF MANUFACTURING THEREOF
DE1802162C (en) N- (2-methyl-3-hydroxy-5-hydroxymethyl-4-pyridylmethylidene) homocysteine thiolactone, its acid addition salts and processes for their preparation
AT288413B (en) Process for the production of new basic xanthone derivatives and their salts
DE1235310B (en) Process for the production of nopinic acid derivatives
AT234700B (en) Process for the preparation of the new 2-methyl-3- (2&#39;-methyl-3&#39;-chlorophenyl) -quinazolons- (4)
DE1670494C3 (en) Boron-containing heterocyclic compounds
AT227703B (en) Process for the preparation of a new sulfonamido compound
DE1004194B (en) Process for the production of uniform, skin-friendly tertiary N- (ª ‰, ª † -dioxypropyl) amines
AT230899B (en) Process for the production of new salts
DE697805C (en) Process for the production of nitrogen-substituted coils of ª ‰ - (p-oxyphenyl) -isopropylamine
DE2235400C3 (en) ^ Chlor-S-sulfamoyl-anthranilic acids, their salts, processes for the preparation of these compounds and medicaments containing these compounds
AT219598B (en) Process for the preparation of new 2- (p-aminobenzenesulfonamido) -5-alkoxypyrimidines

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee